导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.56% | 2067/4773 |
| 近一周 | -2.06% | 1145/5462 |
| 近一月 | -3.72% | 1922/5421 |
| 近一季 | -6.48% | 2105/5209 |
| 近半年 | -1.65% | 1656/4920 |
| 近一年 | 3.21% | 1971/4366 |
| 近两年 | 49.37% | 1483/2954 |
| 近三年 | 30.59% | 1033/2253 |
| 成立以来 | 571.56% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.16% 2704/4961 |
12.58% 2154/5312 |
- - |
- - |
| 2025 | 20.78% 2091/4813 |
0.69% 1786/3635 |
2.61% 1465/4076 |
16.44% 2649/4524 |
0.39% 2023/4813 |
| 2024 | 15.67% 900/3463 |
4.28% 463/2808 |
-1.69% 1095/3014 |
15.63% 1669/3129 |
-2.42% 2074/3463 |
| 2023 | -7.72% 943/2656 |
3.44% 1197/2280 |
-2.78% 664/2385 |
-1.66% 561/2515 |
-6.69% 1877/2655 |
| 2022 | -16.51% 485/2207 |
-10.77% 421/1919 |
7.67% 441/2016 |
-13.73% 962/2113 |
0.73% 1459/2208 |
| 2021 | -6.26% 1001/1822 |
-2.34% 624/1255 |
3.78% 956/1330 |
-6.70% 981/1466 |
-0.86% 1281/1822 |
| 2020 | 29.08% 549/1250 |
-9.06% 653/1028 |
13.06% 653/1067 |
11.40% 455/1164 |
12.71% 440/1184 |
| 2019 | 34.58% 398/1092 |
24.11% 528/754 |
0.28% 180/804 |
0.92% 443/850 |
7.14% 479/918 |
| 2018 | -21.46% 213/834 |
- - |
- - |
- - |
-11.55% 315/691 |
| 2017 | 27.03% 96/714 |
- - |
- - |
- - |
- - |
| 2016 | -3.74% 147/605 |
- - |
- - |
- - |
- - |
| 2015 | 18.70% 125/575 |
- - |
- - |
- - |
- - |
| 2014 | 57.77% 44/237 |
- - |
- - |
- - |
- - |
| 2013 | -6.31% 113/186 |
- - |
- - |
- - |
- - |
| 2012 | 8.25% 59/140 |
- - |
- - |
- - |
- - |
| 2011 | -23.55% 60/102 |
- - |
- - |
- - |
- - |
| 2010 | -11.98% 30/58 |
- - |
- - |
- - |
- - |
| 2009 | 88.61% 10/27 |
- - |
- - |
- - |
- - |
| 2008 | -63.88% 18/26 |
- - |
- - |
- - |
- - |
| 2007 | 122.70% 17/22 |
- - |
- - |
- - |
- - |
| 2006 | 120.74% 8/14 |
- - |
- - |
- - |
- - |
| 2005 | -4.09% 9/11 |
- - |
- - |
- - |
- - |
| 2004 | -10.85% 4/4 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 博时沪深300指数A VS. 长安沪深300非周期A(740101) |